IBEX IBEX Limited
$45.94▼ -2.44%
Technology
Other
After hours
$45.94▲ +0.00%
Oct 27, 4:00 PM ET
Volume 76.5K
Avg Volume (10D) 87.8K
Key Metrics & Fundamentals
Market Cap
$610.02M
P/E Ratio
14.7
Div Yield
0.00%
52W Range
25.94 - 48.17
% vs 50 MA
10.44%
% vs 200 MA
34.66%
RSI-14
61.6
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.54
Free Cash Flow
$21.66M
Gross Rev
$164.27M
Gross Profit
$46.92M
EBITDA
$15.56M
COGS
$117.35M
Operating Exp
$37.10M
Operating Income
$9.82M
EBIT
$9.82M
Pretax Income
$9.72M
Net Income
$8.75M
EPS (Diluted)
0.59
Price & Volume History
Loading chart…
Recent News
IBEX Limited to Announce First Quarter 2027 Financial Results on November 5, 2026
GlobeNewswire · Oct 22, 2026 4:15 PM ET
ibex Wins 2026 Product of the Year Award from CUSTOMER Magazine
GlobeNewswire · Sep 24, 2026 9:00 AM ET
Ibex Insider Sold Shares Worth $395,728, According to a Recent SEC Filing
MT Newswires · Sep 16, 2026 5:31 PM ET
ibex Wins 2026 Globee® Award for AI-Powered Customer Experience Solution Excellence
GlobeNewswire · Sep 16, 2026 9:00 AM ET
IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine
Insider Monkey · Sep 13, 2026 8:19 AM ET
Why Ibex Stock Crushed it on Friday
Motley Fool · Sep 11, 2026 7:31 PM ET
IBEX Ltd (IBEX) (Q4 2026) Earnings Call Highlights: Record Revenue and AI-Driven Growth Momentum
GuruFocus.com · Sep 11, 2026 3:00 AM ET
IBEX (IBEX) Q4 2026 Earnings Call Transcript
Motley Fool · Sep 10, 2026 10:42 PM ET
IBEX Limited Q4 2026 Earnings Call Summary
Moby · Sep 10, 2026 8:30 PM ET
IBEX Q4 Earnings Call Highlights
MarketBeat · Sep 10, 2026 6:03 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IBEX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.